KIF3C is associated with favorable prognosis in glioma patients and may be regulated by PI3K/AKT/mTOR pathway

ConclusionThis study demonstrated that KIF3C might inhibit glioma growth to prolong survival time by regulating the PI3K/AKT/mTOR pathway, providing a potential therapeutic target in glioma.

Source: Journal of Neuro-Oncology - January 31, 2020 Category: Cancer & Oncology Source Type: research